The Israelis have focused on unique opportunities of major diseases for which existing therapies are largely ineffective including treatments for cardiovascular and peripheral vascular disease, oncology, neurodegenerative disease, ophthalmic, and orthopedic as well as health and wellness solutions.


This connector assists qualified Israeli bio-pharma, medical device, and health IT companies by making introductions and contacts to potential strategic and clinical partners in the Southeast.

Ralph Jordan, Chair

join connector committee button

The Israeli Life Science Industry 2012 Summary Report